Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

dc.contributor.authors	Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U,Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO
dc.date.accessioned	2020-02-27T08:42:35Z
dc.date.available	2020-02-27T08:42:35Z
dc.date.issued	2015
dc.identifier.citation	Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U,Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO (2015). Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? . Int J Clin Oncol. , 20(1), 81-70
dc.identifier.uri	https://doi.org/ 10.1007/s10147-014-0672-8.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66763
dc.title	Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
dc.identifier.volume	20(1)
dc.identifier.startpage	70
dc.identifier.endpage	81
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Int J Clin Oncol.
dc.identifier.doi	10.1007/s10147-014-0672-8.
dc.contributor.author	Bayoğlu, İbrahim Vedat